The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What's wrong with Bonferroni adjustments
Perneger, T. V. (1998) · BMJ · doi:10.1136/bmj.316.7139.1236 · Cited by 5,900
J Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02586.x · Cited by 2,073
Statistical methods in medical research
Menduke, H. (1972) · Journal of the Franklin Institute · doi:10.1016/0016-0032(72)90050-6 · Cited by 1,263
A population-based study of seizures after traumatic brain injuries
Annegers, J. F., Hauser, W. A., Coan, S. P., & Rocca, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801013380104 · Cited by 1,090
A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables
Mehta, C. R., & Patel, N. R. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477989 · Cited by 898
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Cellular changes in the postmortem hippocampus in major depression
Stockmeier, C. A., Mahajan, G. J., Konick, L. C., Overholser, J. C., Jurjus, G. J., Meltzer, H. Y., Uylings, H. B. M., Friedman, L., & Rajkowska, G. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.022 · Cited by 732 · cited 1×
“Postmortem neuroathological examination of depressed patients has indicated ippocampal atrophy (Stockmeier et al. 2004), which is a classic inding in partial epilepsy, although the patterns of neuron prouting and loss may differ between epilepsy and mood isorders (Bausch 2005; de Lanerolle and Lee…”
BackgroundDepression but not seizure frequency predicts quality of life in treatment-resistant epilepsy
Boylan, L. S., Flint, L. A., Labovitz, D. L., Jackson, S. C., Starner, K., & Devinsky, O. (2004) · Neurology · doi:10.1212/01.wnl.0000103282.62353.85 · Cited by 644
The psychiatric comorbidity of epilepsy
Gaitatzis, A., Trimble, M. R., & Sander, J. W. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00324.x · Cited by 581
Cited by
Rossi, S., Antal, A., Bestmann, S., Bikson, M., Brewer, C., Brockmöller, J., Carpenter, L. L., Cincotta, M., Chen, R., Daskalakis, J. D., et al. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.10.003 · Cited by 1,573
“one study evaluating the rate of seizures in the placebo (and treatment separately) arm of antidepressant drug studies (Alper et al., 2007).”
Comorbidities of epilepsy: current concepts and future perspectives
Keezer, M. R., Sisodiya, S. M., & Sander, J. W. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00225-2 · Cited by 778
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
“…threshold, systematic review of data from placebo-controlled trials with psychotropic drugs, submitted to the United States Federal Drug Administration, indicates that that the frequency of seizures is significantly lower with most antidepressants than with placebo [I (M)] (Alper et al., 2007).”
BackgroundHasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & the Wfsbp Task Force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.696143 · Cited by 637
Management of psychiatric and neurological comorbidities in epilepsy
Kanner, A. M. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.243 · Cited by 451
Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan
Lin, J. J., Mula, M., & Hermann, B. P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61455-x · Cited by 435
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & WFSBP Task force on Treatment Guidelines for Schizophrenia (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.739708 · Cited by 416
Depression and cognitive complaints following mild traumatic brain injury
Silver, J. M., McAllister, T. W., & Arciniegas, D. B. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08111676 · Cited by 315
“The propensity of bupropion to reduce seizure threshold is a concern in the firstline use of this agent, although the risk of early and late seizures after mild TBI is relatively low (51), and the risk of seizures with bupropion appears to be restricted to the immediate-release formulation (52).”
BackgroundAddressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299
Kanner, A. M., Schachter, S. C., Barry, J. J., Hersdorffer, D. C., Mula, M., Trimble, M., Hermann, B., Ettinger, A. E., Dunn, D., Caplan, R., et al. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.01.007 · Cited by 295
The neurobehavioural comorbidities of epilepsy: can a natural history be developed?
Hermann, B., Seidenberg, M., & Jones, J. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70018-8 · Cited by 291
The expanding evidence base for rTMS treatment of depression
George, M. S., Taylor, J. J., & Short, E. B. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835ab46d · Cited by 288
Psychiatric Comorbidities in People With Epilepsy
Mula, M., Kanner, A. M., Jetté, N., & Sander, J. W. (2021) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000874 · Cited by 256
Psychiatric comorbidities in epilepsy.
Josephson, C. B., & Jetté, N. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1302412 · Cited by 224
“Furthermore, olanzapine, molecularly similar to clozapine, also induces similar EEG changes (Centorrino et al., 2002), although its association with seizures is less consistent (Alper et al., 2007).”
BackgroundInfluentialHill, T., Coupland, C., Morriss, R., Arthur, A., Moore, M., & Hippisley-Cox, J. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0701-9 · Cited by 91
Cognitive disorders in epilepsy I: Clinical experience, real-world evidence and recommendations
Kanner, A. M., Helmstaedter, C., Sadat-Hossieny, Z., & Meador, K. (2020) · Seizure · doi:10.1016/j.seizure.2020.10.009 · Cited by 89
Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113480990 · Cited by 69
“The confounding issues, the previous safety profile of other NK1 antagonists, the lack of any preclinical signal of proconvulsant activity, as well as epidemiological studies suggesting that depressed populations have a seizure risk several times that in the normal population (Alper et al., 2007; Hesdorffer et al., 20…”
BackgroundAntidepressants for people with epilepsy and depression
Maguire, M. J., Marson, A. G., & Nevitt, S. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010682.pub3 · Cited by 57
The biopsychosocial model and quality of life in persons with active epilepsy
Elliott, J. O., & Richardson, V. E. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.09.035 · Cited by 56
“This is supported by data from phase II and III clinical trials of psychotropic drugs conducted in the United States between 1985 and 2004, which found that the incidence of seizures was 52% lower in people receiving antidepressants compared to those receiving placebo (104).”
Bloechliger, M., Ceschi, A., Rüegg, S., Kupferschmidt, H., Kraehenbuehl, S., Jick, S. S., Meier, C. R., & Bodmer, M. (2016) · Drug Safety · doi:10.1007/s40264-015-0363-z · Cited by 40
Orjuela-Rojas, J. M., Martínez-Juárez, I. E., Ruiz-Chow, A., & Crail-Melendez, D. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.07.033 · Cited by 37
Bupropion, a brief history of seizure risk
Tripp, A. C. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.11.004 · Cited by 26
Li, Y., Gao, J., He, S., Zhang, Y., & Wang, Q. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0179-6 · Cited by 26
Köster, M., Grohmann, R., Engel, R. R., Nitsche, M. A., Rüther, E., & Degner, D. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3281-8 · Cited by 18
Psychological treatments for people with epilepsy
Michaelis, R., Tang, V., Nevitt, S. J., Wagner, J. L., Modi, A. C., LaFrance Jr, W. C., Goldstein, L. H., Gandy, M., Bresnahan, R., Valente, K., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012081.pub3 · Cited by 37
Optimizing Management of Medically Responsive Epilepsy
Bauer, D., & Quigg, M. (2019) · Continuum · doi:10.1212/con.0000000000000709 · Cited by 14
Metadata
- Authors
- Alper, K., Schwartz, K. A., Kolts, R. L., & Khan, A.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 62
- Issue
- 4
- Pages
- 345-354
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2027711489
- Cited by
- 522
- References
- 115
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.